Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

bacopaside I

Known as: 3-O-alpha-L-arabinofuranosyl-(1-2)-(6-O-sulphonyl-beta-D-glucopyranosyl-(1-3))-alpha-L-arabinopyranosyl pseudo-jujubogenin 
 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

SaponinsTriterpenes

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Antidepressant-like Effect of Bacopaside I in Mice Exposed to Chronic Unpredictable Mild Stress by Modulating the Hypothalamic–Pituitary–Adrenal Axis Function and Activating BDNF Signaling Pathway
Preliminary studies conducted in our laboratory have confirmed that Bacopaside I (BS-I), a saponin compound isolated from Bacopa… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2016
2016
Controversies of Pioglitazone in the Management of Diabetes Mellitus
Type II-diabetes mellitus (T2DM) is a chronic metabolic disorder which is treated with oral hypoglycaemic agents including… Expand
Is this relevant?
2013
2013
Neuroprotective effects of bacopaside I in ischemic brain injury.
PURPOSE Bacopa monnieri (L.) WETTST. is extensively used in traditional Indian medicine as a nerve tonic. The… Expand
Is this relevant?
2011
2011
Synthesis and antidepressant-like activity evaluation of sulphonamides and sulphonyl-hydrazones.
In this study a series of sulphonamides and sulphonyl hydrazones of maleimide, naphthalimide and phthalimide derivatives was… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2011
2011
DEVELOPMENT AND EVALUATION OF TWO LAYERED TABLET OF GLIMEPIRIDE AND METFORMIN HYDROCHLORIDE FOR THE TREATMENT OF HYPERGLYCEMIA
The aim of the present work was to develop a robust formulation of Bi-layer tablets of Glimepiride and Metformin Hydrochloride… Expand
Is this relevant?
2001
2001
Nateglinide: A structurally novel, short-acting, hypoglycemic agent.
Nateglinide is a short-acting, pancreatic, beta-cell-selective, K(ATP) potassium channel blocker that improves overall glycemic… Expand
Is this relevant?
1998
1998
Normalization of fasting glycaemia by intravenous GLP-1 ([7-36 amide] or [7-37]) in type 2 diabetic patients.
Intravenous GLP-1 [7-36 amide] can normalize fasting hyperglycaemia in Type 2 diabetic patients. Whether GLP-1 [7-37] has similar… Expand
Is this relevant?
1995
1995
Mechanisms of free-radical scavenging by the nutritional antioxidant beta-carotene.
p-Carotene (pro-vitamin A) is a lipid-soluble antioxidant capable of quenching singlet oxygen and scavenging free-radical species… Expand
  • figure 1
Is this relevant?
1994
1994
Effect of a novel CCKA receptor antagonist (2-NAP) on the reduction in food intake produced by CCK in pigs
The effect of a novel CCKA receptor antagonist 2-naphthalene sulphonyl-L-aspartyl-2-(phenethyl)amide, sodium salt (2-NAP) on the… Expand
Is this relevant?
1971
1971
Isolation and nature of intracellular peptides from a cephalosporin C-producing Cephalosporium sp.
1. Three peptides containing alpha-aminoadipic acid and cysteine have been obtained in small amounts from the mycelium of a… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE